Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
117.25
-2.47 (-2.06%)
At close: Feb 9, 2026, 4:00 PM EST
117.60
+0.35 (0.30%)
After-hours: Feb 9, 2026, 5:37 PM EST
Illumina Revenue
In the year 2025, Illumina had annual revenue of $4.34B, down -0.66%. Illumina had revenue of $1.16B in the quarter ending December 28, 2025, with 4.98% growth.
Revenue (ttm)
$4.34B
Revenue Growth
-0.66%
P/S Ratio
4.18
Revenue / Employee
$418,804
Employees
10,370
Market Cap
17.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 4.34B | -29.00M | -0.66% |
| Dec 29, 2024 | 4.37B | -132.00M | -2.93% |
| Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
| Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
| Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
| Jan 3, 2021 | 3.24B | -304.00M | -8.58% |
| Dec 29, 2019 | 3.54B | 210.00M | 6.30% |
| Dec 30, 2018 | 3.33B | 581.00M | 21.11% |
| Dec 31, 2017 | 2.75B | 354.00M | 14.76% |
| Jan 1, 2017 | 2.40B | 178.00M | 8.02% |
| Jan 3, 2016 | 2.22B | 358.64M | 19.27% |
| Dec 28, 2014 | 1.86B | 440.18M | 30.97% |
| Dec 29, 2013 | 1.42B | 272.66M | 23.74% |
| Dec 30, 2012 | 1.15B | 92.98M | 8.81% |
| Jan 1, 2012 | 1.06B | 152.79M | 16.93% |
| Jan 2, 2011 | 902.74M | 236.42M | 35.48% |
| Jan 3, 2010 | 666.32M | 93.10M | 16.24% |
| Dec 28, 2008 | 573.23M | 206.43M | 56.28% |
| Dec 30, 2007 | 366.80M | 182.21M | 98.71% |
| Dec 31, 2006 | 184.59M | 111.09M | 151.13% |
| Jan 1, 2006 | 73.50M | 22.92M | 45.31% |
| Jan 2, 2005 | 50.58M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 13.77B |
| Quest Diagnostics | 10.85B |
| ICON Public Limited Company | 8.10B |
| Mettler-Toledo International | 4.03B |
| Waters | 3.11B |
| Exact Sciences | 3.08B |
| Revvity | 2.86B |
| Medpace Holdings | 2.36B |
ILMN News
- 3 days ago - Illumina, Inc. (ILMN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 - PRNewsWire
- 6 days ago - Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally - PRNewsWire
- 10 days ago - Illumina completes acquisition of SomaLogic - PRNewsWire
- 20 days ago - Illumina Gets Medicare Boost for Cancer Test, Shares Climb - Benzinga
- 20 days ago - Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology - PRNewsWire
- 20 days ago - GRAIL Inc. - Illumina's Divested Holy Grail - Seeking Alpha
- 27 days ago - Illumina, Inc. (ILMN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha